In Vitro Diagnostics
Indi Molecular is the in vivo diagnostic imaging division of Indi. We are creating a new generation of PET (Positron Emission Tomography) imaging probes using InDi’s innovative protein catalyzed capture (PCC) agent technology. PCCs are rationally designed imaging probes that mimic the properties of antibodies and biologics in PET molecular imaging. They come with the benefits of being chemically stable, synthetic small-molecules.
PCCs are built using the principles of modular chemistry, which makes them remarkably versatile; they are ideal for use as in vivo imaging PET probes. Using this technology, we are pursuing multiple disease targets in a way that would be difficult or impossible using standard antibody- or phage-display approaches.
We expect to pursue our first human studies of PCC-based imaging products in 2013.
PET Imaging Primer
PET is a molecular imaging technique that provides in vivo images of biological processes, blood flow, metabolism, cell communication systems, drug interactions and gene expression. The technology has many important clinical applications in the diagnosis of human disease, and monitoring of therapeutic modalities.
There are 2,400 clinical PET imaging centers in America, as well as PET clinical services throughout the rest of the world. While uniquely providing molecular imaging diagnostics of disease, the unique principles of PET have provided its molecular imaging diagnostics in approximately 37 million clinical studies without a single reported complication.